23 May 2013
Keywords: orapharma, mucositis, drug, track, successfully, completed, phase
Article | 12 August 2002
OraPharma has successfully completed a Phase I clinical trial of itssecond product candidate, OC-1012 for the prevention of mucositis, at
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 February 2002
22 May 2013
© 2013 thepharmaletter.com